Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Cancer Female × Bupivacaine × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Pain, Postoperative 2 Vesico-Ureteral Reflux 1 Uterine Neoplasms 1 Ureteral Neoplasms 1 Peritoneal Cancer 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Neuralgia 1 Nephrolithiasis 1 Neoplasms 1 Malignant Neoplasms of Female Genital Organs 1 Lung Neoplasms 1 Leiomyoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Digestive System Diseases 1 Breast Cancer Female 1 Abdominal Cancer 1

Interventions

Tamoxifen 2 pegfilgrastim 1 exemestane 1 abemaciclib 1 Tretinoin 1 Tocopherols 1 Standard of Care 1 Mifepristone 1 Letrozole 1 Isotretinoin 1 Dexmedetomidine 1 Cannabidiol 1 Bupivacaine 1 Anastrozole 1 Alitretinoin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡